NB
Nandita Biswas
About Nandita Biswas
Data last updated:
Nandita Biswas is a Director at Sydney Healthcare Private Limited (since 2017) and Director at Sunasu Laboratories Private Limited (since 2022). The companies operate in Pharma. The largest current company by reported revenue is Sydney Healthcare Private Limited at ₹1.4 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sydney Healthcare Private Limited U74999WB2017PTC219957 | Director | 14 Mar 2017 | 2017 | ₹1.4 Lakh (FY 2019) | Active |
| Sunasu Laboratories Private Limited U24239WB2022PTC252031 | Director | 03 Mar 2022 | 2022 | Active |
Board colleagues of Nandita Biswas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kedar Nath Roy | 07686706 | Sydney Healthcare Private Limited | Director |
| Susanta Biswas | 09526263 | Sunasu Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nandita Biswas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nandita Biswas
Nandita Biswas currently holds 2 directorships: Sydney Healthcare Private Limited (Director, since 14 Mar 2017, revenue ₹1.4 Lakh (FY 2019)); Sunasu Laboratories Private Limited (Director, since 03 Mar 2022).
Nandita Biswas was first appointed on 14 Mar 2017 as Director at Sydney Healthcare Private Limited. The most recent appointment on record is 03 Mar 2022 at Sunasu Laboratories Private Limited.
The current boards of Nandita Biswas's companies include Kedar Nath Roy (Sydney Healthcare Private Limited), Susanta Biswas (Sunasu Laboratories Private Limited).